Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice.
These devices have a knack for attracting cancer cells traveling through the body. In fact, they can even pick up signs that cancer is preparing to spread, before cancer cells arrive.
“Biopsying an organ like the lung is a risky procedure that’s done only sparingly,” said Lonnie Shea, the William and Valerie Hall Chair of biomedical engineering at U-M. “We place these scaffolds right under the skin, so they’re readily accessible.”
The ease of access would also allow doctors to monitor the effectiveness of cancer treatments closer to real time.
The U-M team’s most recent work appears in Cancer Research, a publication of the American Association for Cancer Research.
Biopsies of the scaffold allowed researchers to analyze 635 genes present in the captured cancer cells. From these genes, the team identified ten that could predict whether a mouse was healthy, if it had a cancer that had not begun to spread yet, or if a cancer was present and had begun to spread. They could do that all without the need for an invasive biopsy of an organ.
The gene expression obtained at the scaffold had distinct patterns relative to cells from the blood, which are obtained through a technique known as liquid biopsy. These differences highlight that the tissue in these traps provides unique information that correlates with disease progression.
The researchers have demonstrated that the synthetic scaffolds work with multiple types of cancers in mice, including pancreatic cancer. They work by luring immune cells, which, in turn, attract cancer cells.
“When we started off, the idea was that we would biopsy the scaffold and look for tumor cells that had followed the immune cells there,” Shea said. “But we realized that by analyzing the immune cells that gather first, we can detect the cancer before it’s spreading.”
In treating cancer, early detection is key.
“Currently, early signs of metastasis can be difficult to detect,” said Jacqueline Jeruss, an associate professor of surgery and biomedical engineering and a co-author of the study. “Imaging may be done once a patient experiences symptoms, but that implies the number of cancer cells may already be substantial. Improved detection methods are needed to identify metastasis at a point when targeted treatments can have a significant beneficial impact on slowing disease progression.”
The immune cells allowed researchers to identify whether treatments were effective in the mice and which subjects were sensitive or resistant to treatment.
The decoy’s ability to draw immune and cancer cells can also bolster the treatment itself. In previous research, the devices demonstrated an ability to slow the growth of metastatic breast cancer tumors in mice, by reducing the number of cancer cells that can reach those tumors.
In the future, Shea envisions that the scaffolds could be outfitted with sensors and Bluetooth technology that could deliver information in real time without the need for a biopsy.
The Latest on: Biopsies
[google_news title=”” keyword=”biopsies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biopsies
- Gynecological care in Ontario is a shambleson December 4, 2023 at 7:59 am
OPINION: After almost a year and half of emergency-room visits, iron infusions, internal exams, and biopsies, I am finally having surgery. It shouldn’t have to be this way.
- Sask. will send women who need urgent breast cancer tests to Calgaryon November 29, 2023 at 5:08 pm
The temporary measure, which is meant to reduce wait times for breast mammography and biopsies, will be in place until the services are "stabilized" in Saskatchewan, the release said. The Regina ...
- MRIs, MRI-Guided Biopsies Detect Prostate Cancer Affordablyon November 29, 2023 at 11:02 am
Standard biopsies sometimes fail to detect prostate cancer or produce false positives. MRI plus MRI-guided biopsies not only produce more accurate results but carry a fair price tag, researchers said.
- S15 Sensitivity of surgical pleural biopsies following a previous negative pleural biopsyon November 26, 2023 at 4:35 am
Introduction and Objectives Ultrasound-Guided (USG) and Local-Anaesthetic Thoracoscopy (LAT) Pleural Biopsies are performed to investigate pleural disease. Though often sufficient to make a diagnosis, ...
- Device for noninvasive brain biopsies via blood draw moves closer to market approvalon November 17, 2023 at 4:00 pm
A device aimed at enabling neurosurgeons and other physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration (FDA) "Breakthrough ...
- Skin biopsies in mammalson November 14, 2023 at 5:48 pm
This column reviews the indications and techniques for performing skin biopsies. Suspicious conditions for which the therapy is expensive, dangerous, or sufficiently time-consuming to necessitate ...
- Biopsies from Healthy Volunteers to Advance Precision Medicineon November 10, 2023 at 4:00 pm
Is it ethically acceptable to obtain tissue from healthy volunteers to enable comparisons with tissue from patients? The answer may depend on the accessibility of the tissue in question ...
- Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsieson October 18, 2023 at 6:40 am
METHODS Fifty two patients with sural nerve biopsies reported to show tomacula or focal myelin swellings were reviewed, light and electron microscopy were performed, and tomacula were analysed on ...
via Bing News